Emergence of Indigenous Artemisinin Resistant Plasmodium falciparum in Africa
Type
BioprojectDataset
Authors
Lu, FengCulleton, Richard
Zhang, Meihua
Ramaprasad, Abhinay

von Seidlein, Lorenz
Zhou, Huayun
Zhu, Guoding
Tang, Jianxia
Liu, Yaobao
Wang, Weiming
Cao, Yuanyuan
Xu, Sui
Gu, Yaping
Li, Julin
Zhang, Chao
Gao, Qi
Menard, Didier
Pain, Arnab

Yang, Haitao
Zhang, Qingfeng
Cao, Jun
KAUST Department
Bioscience ProgramBiological and Environmental Sciences and Engineering (BESE) Division
Date
2017-02-24Permanent link to this record
http://hdl.handle.net/10754/666457
Metadata
Show full item recordAbstract
Plasmodium falciparum has developed resistance to artemisinin in Southeast Asia. Artemisinin combination therapy (ACT) is the first line treatment for malaria in the majority of endemic countries, and its efficacy is of particular importance in Africa where malaria exerts its greatest burden. We report here the first case of an artemisinin resistant strain of P. falciparum from Africa.Publisher
NCBIAdditional Links
https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJEB18721Relations
Is Supplement To:- [Article]
Lu F, Culleton R, Zhang M, Ramaprasad A, von Seidlein L, et al. (2017) Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa. New England Journal of Medicine. Available: http://dx.doi.org/10.1056/nejmc1612765.. DOI: 10.1056/nejmc1612765 Handle: 10754/622941